Survey of oncology providers on psychosocial distress

描述（由申请人提供）： 概述和背景：本R 03申请建议调查肿瘤学提供者对心理社会困扰筛查的实践。虽然国家综合癌症网络（NCCN）指南已经发布了近五年，但没有关于其使用范围的数据。如果在现有的肿瘤治疗系统中改善癌症患者的心理社会护理的努力是成功的，目前的常规做法的数据是至关重要的。基于研究表明，肿瘤提供者对痛苦的识别很差，这项调查的重点是筛查痛苦，这是NCCN指南的切入点。通过研究这一关键时刻，进一步努力改善心理社会护理可以量身定制的肿瘤学家的做法报告。 主要目的：本研究的目的是管理一个全国性的调查肿瘤学家使用NCCN指南筛查癌症患者的痛苦。本申请由两位初级研究人员Pirl博士和Muriel博士提交，他们将接受Kornblith博士的指导。 研究方法：在一个简短的启动阶段，我们将通过从马萨诸塞州的10位肿瘤学家那里获得关于该仪器的系统反馈来收集调查问卷的可接受性数据。如有需要，我们将修订问卷。在第一年，我们将通过电子邮件向马萨诸塞州的400多名美国临床肿瘤学会（ASCO）会员肿瘤学家分发调查。在第二年，我们将把调查范围扩大到从ASCO国家会员名录中随机选择的1,000名肿瘤学家。将使用调查中每个项目的频率分布来分析数据。 奖励机制：该项目使用R-03，小额赠款机制，遵循“癌症控制行为研究小额赠款”的计划公告。这一机制的目标是初级研究人员和研究，这将“促进一个全国性的科学家群体的增长，他们在行为癌症控制研究方面具有高水平的研究专业知识。“这项调查的数据将使研究人员能够继续他们对癌症护理模式的研究计划，这些模式将癌症痛苦筛查与开发和测试以证据为基础的干预措施相结合。它还将以低成本评估NCCN痛苦筛查指南的使用和效用，必要时提供数据，以证明进一步努力将痛苦筛查扩展到常规癌症护理的合理性。

DESCRIPTION (provided by applicant): Overview and Background: This R03 application proposes to survey oncology providers about their practices of screening for psychosocial distress. Although the National Comprehensive Cancer Network (NCCN) guidelines have been published for almost five years, there is no data on the extent of their use. If efforts at improving the psychosocial care of cancer patients within existing oncology treatment systems are to be successful, data on current routine practices are critically important. Building on research that demonstrates that distress recognition by oncology providers is poor, this survey focuses on screening for distress, the entry point of the NCCN guidelines. By examining this crucial juncture, further efforts at improving the psychosocial care can be tailored to the reported practices of oncologists. Primary Aim: The goal of this study to administer a nation-wide survey of oncologists on the use of the NCCN guidelines for screening for distress in cancer patients. This application is being submitted by two junior investigators, Drs. Pirl and Muriel, who will receive the mentorship of Dr. Kornblith for the study. Methods: During a brief start-up phase, we will gather acceptability data on the survey questionnaire by obtaining systematic feedback on the instrument from ten oncologists in Massachusetts. As needed, we will revise the questionnaire. In year 1, we will distribute the survey by email to over 400 oncologists in Massachusetts who are members of the American Society of Clinical Oncology (ASCO). In year 2, we will extend the survey to 1,000 randomly selected oncologists from the national membership directory of ASCO. Data will be analyzed using frequency distributions on each item of the survey. Mechanism of award: This project uses the R-03, small grant mechanism, following the program announcement for "Small grants for behavioral research in cancer control." This mechanism targets junior investigators and research that will "facilitate the growth of a nationwide cohort of scientists with a high level of research expertise in behavioral cancer control research." The data from this survey will allow the investigators to continue their program of research on models of cancer care that integrate screening for distress in cancer and developing and testing evidence-based interventions that emphasize. It will also, with a low cost, allow for the evaluation of the use and utility of the NCCN guidelines for distress screening, providing data, if necessary, to justify further efforts to extend distress screening into regular cancer care.